Biomarker ID | 1393 |
PMID | 24722180 |
Year | 2014 |
Biomarker | Testosterone |
Biomarker Basis | Concentration Based (ng/dl) |
Biomolecule | Hormone |
Source | Plasma |
Subjects | Humans |
Regulation | Increased levels in patients with Higher overall Survival |
Odds Ratio/Hazard Ratio/Relative Risk | HR: 0.5 (95% CI: 0.3–0.9) |
Effect on Pathways | NA |
Experiment | Overall Survival Vs No Survival |
Type of Biomarker | Prognostic |
Cohort | In a cohort of 101 mCRPC patients participating in 9 non-hormonal first-line chemotherapy phase II–III trials were selected |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p=0.018 |
Method Used | automated immunoassay |
Clinical | No |
Remarks | Inclusion criteria in all trials required a TL of <50 ng/dl |
Clinical Trial Number | NA |
Degree Of Validity | NA |
Technical Name | NA |